Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net sales	$ 362	$ 494
Cost of sales	(309)	(409)
Gross profit	53	85
Selling, general and administrative expenses	(44)	(52)
Research, development and engineering expenses, net	(131)	(156)
Amortization of intangibles	(1)	(5)
Other income, net	1	0
Operating loss	(122)	(128)
Gain (loss) on divestiture and assets held for sales, net	(67)	0
Loss from equity method investment	(18)	(17)
Interest income	4	3
Interest expense	(5)	0
Loss before income taxes	(208)	(142)
Income tax expense	(23)	(6)
Net loss	(231)	(148)
Less: Net income (loss) attributable to non-controlling interest	2	(11)
Net loss attributable to controlling interest	$ (233)	$ (137)
Net loss per share - basic (in dollars per share)	$ (2.09)	$ (1.57)
Net loss per share - diluted (in dollars per share)	$ (2.09)	$ (1.57)
Weighted average number of shares outstanding, (in millions) (in shares)	111,470	87,240
Weighted average number of shares outstanding, assuming dilution (in millions) (in shares)	111,470	87,240